Influence of Febrile Neutropenia Period on Plasma Viscosity at Malignancy

Table 1

Patient's demographic, clinic, and laboratory results.

Characteristics	𝑛
Gender
Male	16
Female	11
MASCC risk index
High (<21)	27
Low (≥21)	0
Underlying cancer
Hematological	20
Solid tumors	7
Patients status at presentation
Inpatients	17
Outpatients	10
Burden of illness
Mild signs	20
Severe signs	7
ECOG performance status
0–2	20
3-4	7
Disease status
Controlled	19
Uncontrolled	8
Treatment setting
Induction (hematological)	3
Consolidation (hematological)	17
Locally advanced (solid tumors)	5
Adjuvant (solid tumors)	2
Infection documentation
Microbiologically documented	7
Fever of unknown origin	20

MASCC: multinational association for supportive care in cancer; ECOG: eastern cooperative oncology group.